32 C
Sunday, June 16, 2024

Can psoriasis increase cardiovascular disease risk? Know what study says

A chronic immune system illness, psoriasis creates red, scaly skin. Chronic, thus it may last long. Psoriasis is thought to be caused by an overactive immune system. Heredity and stress or infection may be mixed. Raised, red, scaly skin can be annoying and uncomfortable. UV light therapy, oral or injectable medicines, and topicals are common treatments. Psoriasis is not contagious and has no cure, but good care and lifestyle adjustments help control it.

Psoriasis, a chronic, systemic, immune-mediated inflammatory illness, may raise cardiovascular disease risk, according to a recent study.

Heart attacks and strokes kill more than psoriasis, which affects 1% to 3% of the world.

Italian University of Padova investigated 503 psoriasis patients without cardiovascular illness who had transthoracic Doppler echocardiography for coronary microcirculation.

Over 30% of asymptomatic patients had significant coronary microvascular dysfunction, researchers observed.

Researchers have found that severe psoriasis increases cardiovascular morbidity and mortality. As the study’s principal investigator, dermatologist Stefano Piaserico said there hasn’t been much investigation into the causes of this increased risk, notably coronary microvascular dysfunction.

The study indicated that psoriatic arthritis prevalence, PASI score, and disease duration independently reduce CFR.

Smoking, hyperlipidemia, and diabetes did not lower CFR in severe psoriasis patients.

Piaserico advised us to screen psoriasis patients for microvascular dysfunction because they are at risk.

Piaserico noted, “Early and effective psoriasis treatment may improve function and lower myocardial infarction and heart failure risk.


Chronic psoriasis generates red, scaly areas and affects the immune system. A hyperactive immune system may be to blame. Environmental factors including stress and infection may also influence. We offer UV light therapy, oral or injectable medications, and topicals. Psoriasis is not communicable and has no cure, although therapy and lifestyle changes can control it. Over 30% of asymptomatic patients have coronary microvascular dysfunction, according to Padova University researchers. Psoriatic arthritis incidence, PASI score, and duration are related with lower CFR. Traditional cardiovascular risk factors did not lower CFR in severe psoriasis patients. Myocardial infarction and heart failure can be prevented with effective psoriasis treatment.


Related Articles

Latest Articles